Drug rationality profile in diabetes mellitus patients
Keywords:
drug rationality, Diabetes Mellitus (DM) Type 2, medical recordAbstract
Diabetes mellitus was a metabolic disease characterized by hyperglycemia that occured due to the inability of the pancreas to secrete insulin, impaired insulin action, or both. According to Riskesdas data (2018), the prevalence of diabetes mellitus in Jember district was in third place. The increased prevalence was caused by one of them, namely the result of inappropriate drug use. The rationality of the drug could be seen from the accuracy of the type of drug, dosages, patient, dosage of each drug. The purpose of this study was to determine the rationality profile of drugs in patients with diabetes mellitus. This type of research was an observational study with a cross-sectional design. The data collection technique used random sampling, with the number of samples in the study being 43 samples. The sample in this study was medical record data of diabetes mellitus patients. The instruments used in the study were patient medical records, hospital formularies and data recapitulation sheets. Data was processed descriptively displayed in the form of frequency and percentage. The results showed that the accuracy of the drug was 95,35%, the accuracy of the dosage was 100%, the accuracy of the patient was 100%, the accuracy of the drug indication was 95,35%, so it was concluded that the rationality of the drug was 97,67%. Drugs were given based on indications, doses, drugs, and patient conditions. Physician provided drug therapy according to hospital procedures that refered to the hospital formulary.
References
ADA. Standards Of Medical Care in Diabetes. The Journal of Clinical and Applied Research and Education, 41(1), (2018). S1–S3. https://doi.org/https://doi.or/10.2337/dc18-SPPC01.
Kementrian kesehatan RI. Tetap produktif, Cegah dan Atasi Diabetes Melitus. In Wi. Widiantini (Ed.), pusat data dan informasi kementrian kesehatan RI (2020). .(pp. 01–10). Jakarta : Kementerian Kesehatan RI Pusat data dan Informasi.
Riskesdas. Laporan Nasional RISKESDAS 2018. Jakarta : (2018). Badan Penelitian dan Pengembangan Kesehatan.
Katzung, B.G., Masters, S.B. dan Trevor, A. . (2014). Farmakologi Dasar & Klinik.
Decroli, E. Diabetes Melitus Tipe 2 (Edisi Pert). (2019). Pusat Penerbit Bagian Ilmu Dalam.
Permenkes. Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 Tentang Standar Pelayanan Kefarmasian di Rumah Sakit. Berita Negara Republik Indonesia, (2016). 49, 1–59. https://www.peraturan.go.id/
World Health Organization Global Report. Standarts of Medical Care in Diabetes-2016 : Summary of Revisions. Diabetes Care, (2016). 39(1), S4–S5. https://doi.org/10.2337
ADA. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetesd2020. Classification and Diagnosis of Diabetes, (2020). 43(1), S14–S31. https://doi.org/10.2337/dc20-S002
Man Kovy. Evaluasi Penggunaan Obat Antidiabetes Oral Pada Pasien Diabetes Melitus Tipe II Rawat Jalan di RSUD. Prof. dr. Soekandar Tahun 2016. (2019) Universitas Islam Negeri Maulana Malik Ibrahim Malang.
Sihotang, R. C., Ramadhani, R., & Tahapary, D. L. Efikasi dan Keamanan Obat Anti Diabetik Oral pada Pasien Diabetes Melitus Tipe 2 dengan Penyakit Ginjal Kronik. Jurnal Penyakit Dalam Indonesia, 5(3), 150.
ADA. Standards Of Medical Care in Diabetes. The Journal of Clinical and Applied Research and Education, (2018). 41(1), S1–S3. https://doi.org/https://doi.or/10.2337/dc18-SPPC01
Europe, P. C. N. Classification for Drug Related Problems. (2010). PCNE. http://www.pcne.org
Widyanti, A. Studi Penggunaan Metformin Pada Pasien Diabetes Melitus Tipe 2 (Penelitian Dilakukan di RSud Dr. Iskak Tulungagung). (2019). Universitas Muhammadiyah Malang.
Mahmudah, I. T. Profil Penggunaan Insulin Rapid Acting Pada Pasien Diabetes Melitus di RSUD Kabupatenn Sidoarjo. (2018). Universitas Katolik Widya Mandala Surabaya.
Panamuan, A. P. M. N., Untari, E. K., & Rizkifan, S. Pengaruh Usia Pasien dan Dosis Terhadap Efek Samping Metformin Pada Pasien Diabetes Tipe 2. Jurnal Farmasi Komunitas, (2021). 8(2), 51–58.
